微血管对阿尔茨海默氏病的贡献 病原:阿尔茨海默氏病主要是一种内皮病吗?
1Department of Neurology, Center for Memory and Aging, University of New Mexico, Albuquerque, NM 87106, USA.
Biomolecules
|May 27, 2023
概括
阿尔茨海默病 (AD) 可能源于早期的血管问题,如血流减少,而不仅仅是蛋白质积累. 解决内皮功能障碍可能会减缓疾病的进展.
科学领域:
- 神经科学是一个神经科学.
- 血管生物学 血管生物学
- 病理学 病理学 病理学
背景情况:
- 传统的阿尔茨海默病 (AD) 模型侧重于神经退行之前的蛋白质聚合.
- 新出现的证据表明血管因素,如毛细血管损失和内皮功能障碍,是AD早期发病事件.
- 这些血管问题可能会先于粉样蛋白和陶聚合,导致神经元损伤.
研究的目的:
- 审查支持AD血管假设的证据.
- 检查血管贡献在阿尔茨海默病发病和进展中的作用.
- 突出早期AD血管修复策略的潜力.
主要方法:
- 临床研究的审查.
- 对成像数据的分析.
- 对神经病理发现的检查.
- 对动物模型的评估.
主要成果:
- 内皮功能障碍与AD的认知衰退相关.
- 血管机制可能是AD发病的主要驱动因素,先于神经退行变化.
- 针对内皮细胞修复的治疗策略显示出早期AD干预的前景.
结论:
- 血管假设为传统的AD模型提供了一个重要的替代方案.
- 早期的血管功能障碍是AD病变发生的关键因素.
- 对血管贡献的进一步研究对于开发有效的AD治疗至关重要.
相关概念视频
01:26Alzheimer's Disease: Overview
539
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
539
01:26Coronary Artery Disease II: Pathophysiology
16
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
16